# Landscape analysis of m6A modification regulators reveals LRPPRC as a key modulator in tubule cells for DKD: a multi-omics study

**Authors:** Li Jiang, Hongda Yu, Jie Jian, Xulin Sai, Yudian Wang, Yufei Zhang, Xiai Wu

PMC · DOI: 10.3389/fphar.2025.1506896 · Frontiers in Pharmacology · 2025-04-04

## TL;DR

This multi-omics study identifies LRPPRC as a key m6A regulator in tubule cells affected by diabetic kidney disease, suggesting its potential role in disease progression.

## Contribution

The study reveals LRPPRC as a novel key modulator of m6A modification in tubule cells during DKD development.

## Key findings

- LRPPRC is downregulated in multiple tubule cell populations and correlates with disease progression in DKD.
- m6A regulators like m6A-readers and m6A-writers are generally suppressed in DKD patients.
- Lobeline is identified as a potential compound for regulating LRPPRC and other m6A genes.

## Abstract

Diabetic Kidney Disease (DKD) is a serious complication of diabetes, imposing a substantial medical burden. The significance of N6-methyladenosine (m6A) modification in the pathogenesis of DKD has become increasingly prominent.

This study aimed to investigate the specific expression patterns of the m6A geneset in the pathogenesis of DKD.

Bulk RNA, single-cell and spatial transcriptome were utilized to clarify the hub gene. 3 types of machine learning algorithms were applied. The possible compounds were screened based on the DSigDB database.

GSEA has revealed the potential m6a-associated pathways such as cGMP-PKG pathway. GSVA showed that the two types of m6a regulation, namely m6a-readers and m6a-writers, were generally suppressed in DKD patients. The output of 3 types of machine learning algorithm and differential analysis has determined the LRPPRC as the hub gene. LRPPRC was downregulated in the LOH, PODO, CT, and CD-ICB cell populations, most of which were tubular cells. It exhibited the decreasing trend over time, particularly pronounced in LOH cells. The low activity of LRPPRC was mainly detected in the injured renal tubules. In clinical patients, the expression levels of LRPPRC mRNA in DKD showed the tendency to be downregulated and exhibited the potential correlations with Glomerular Filtration Rate (GFR) and proteinuria according to the Nephroseq database. The lobeline might be an important potential compound involved in the regulation of LRPPRC and other m6a genes. Its actual efficacy needs to be verified in vivo or in vitro.

## Linked entities

- **Genes:** LRPPRC (leucine rich pentatricopeptide repeat containing) [NCBI Gene 10128]
- **Chemicals:** lobeline (PubChem CID 3945)
- **Diseases:** Diabetic Kidney Disease (MONDO:0005016), DKD (MONDO:0005016)

## Full-text entities

- **Genes:** GPM6A (glycoprotein M6A) [NCBI Gene 2823] {aka GPM6, M6A}, LRPPRC (leucine rich pentatricopeptide repeat containing) [NCBI Gene 10128] {aka CLONE-23970, GP130, LRP130, LSFC, MC4DN5}
- **Diseases:** proteinuria (MESH:D011507), diabetes (MESH:D003920), DKD (MESH:D003928)
- **Chemicals:** N6-methyladenosine (MESH:C010223), lobeline (MESH:D008120)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** CD-ICB — Homo sapiens (Human), Ewing sarcoma, Cancer cell line (CVCL_W328)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12006725/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12006725/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC12006725/full.md

---
Source: https://tomesphere.com/paper/PMC12006725